| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.398 | 60.688 | 57.206 | 42.084 | 32.787 | 2.897 | 4.097 | 12.830 | 8.891 | 7.064 |
| Total Income - EUR | 52.088 | 48.432 | 58.170 | 43.355 | 34.563 | 13.091 | 9.642 | 12.839 | 8.908 | 8.772 |
| Total Expenses - EUR | 54.259 | 45.061 | 52.726 | 54.644 | 38.030 | 6.653 | 3.610 | 5.694 | 8.465 | 8.708 |
| Gross Profit/Loss - EUR | -2.171 | 3.371 | 5.445 | -11.289 | -3.467 | 6.438 | 6.032 | 7.144 | 443 | 64 |
| Net Profit/Loss - EUR | -3.834 | 2.764 | 4.822 | -11.711 | -3.904 | 6.239 | 5.748 | 6.767 | 358 | 24 |
| Employees | 4 | 4 | 4 | 5 | 3 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Andari General Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.674 | 19.877 | 18.061 | 16.300 | 14.636 | 13.107 | 11.619 | 10.455 | 9.226 | 8.824 |
| Current Assets | 23.865 | 11.493 | 15.609 | 4.446 | 3.321 | 4.098 | 11.091 | 16.935 | 13.354 | 12.568 |
| Inventories | 15.022 | 1.620 | 1.981 | 1.733 | 29 | 28 | 0 | 0 | 0 | 0 |
| Receivables | 6.792 | 6.337 | 12.657 | 2.276 | 463 | 57 | 3.964 | 1.525 | 1.234 | 1.761 |
| Cash | 2.052 | 3.536 | 971 | 437 | 2.829 | 4.013 | 7.128 | 15.410 | 12.119 | 10.807 |
| Shareholders Funds | 19.124 | 13.659 | 18.250 | 6.204 | 2.180 | 8.378 | 13.940 | 20.750 | 21.045 | 20.952 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.415 | 17.711 | 15.420 | 14.542 | 15.776 | 8.827 | 8.770 | 6.639 | 1.535 | 441 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andari General Med S.r.l.